XML 47 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Other Assets and Other Liabilities and Deferred Income
9 Months Ended
Sep. 30, 2018
Other Assets and Other Liabilities and Deferred Income [Abstract]  
OTHER ASSETS AND OTHER LIABILITIES AND DEFERRED INCOME
OTHER ASSETS AND OTHER LIABILITIES AND DEFERRED REVENUE

Other assets and other liabilities and deferred revenue consist of various balance sheet items that are combined for financial statement presentation due to their respective materiality compared with other individual asset and liability items.

Other assets were as follows (in millions):
 
December 31,
2017
 
September 30,
2018
Accrued interest and other non-finance receivables
$
1,117

 
$
1,075

Collateral held for resale, at net realizable value, and other inventory

780

 
740

Prepaid reinsurance premiums and other reinsurance recoverables

611

 
651

Deferred charges – income taxes
247

 
225

Property and equipment, net of accumulated depreciation (a)
177

 
187

Restricted cash
124

 
147

Investment in non-consolidated affiliates
107

 
117

Deferred charges
127

 
95

Other
39

 
80

Total other assets
$
3,329

 
$
3,317

__________
(a)
Accumulated depreciation was $354 million and $361 million at December 31, 2017 and September 30, 2018, respectively.

Other liabilities and deferred revenue were as follows (in millions):
 
December 31,
2017
 
September 30,
2018
Unearned insurance premiums and fees
$
723

 
$
769

Interest payable
722

 
572

Income tax and related interest (a)
301

 
290

Deferred revenue
148

 
103

Payroll and employee benefits
68

 
70

Other
310

 
235

Total other liabilities and deferred income
$
2,272

 
$
2,039


__________
(a)
Includes tax and interest payable to affiliated companies of $99 million and $94 million at December 31, 2017 and September 30, 2018, respectively.

We have investments in entities for which we do not have the ability to exercise significant influence and fair values are not readily available. We have elected to record these investments at cost (less impairment, if any), adjusted for changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We report the carrying value of these investments in Other assets in our consolidated balance sheet. These investments were $7 million and $9 million at December 31, 2017 and September 30, 2018, respectively. There were no material adjustments to the fair values of these investments during the period ending September 30, 2018.

Deferred revenue balances presented above include amounts from contracts with customers primarily related to admission fee revenue on group financing products available in Argentina and were $124 million and $76 million at December 31, 2017 and September 30, 2018, respectively.

Admission fee revenue on group financing products is generally recognized evenly over the term of the agreement, which is up to 84 months. Increases in the admission fee deferred revenue balance are the result of payments due during the current period in advance of satisfying our performance under the contract and decreases are a result of revenue recognized during the current period that was previously deferred.